A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

Clinical trial NCT07673029 · RECRUITING

Trial details

NCT number: NCT07673029
Sponsor: GeneQuantum Healthcare (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HER2-positive Breast Cancer

Start date: 2025-01-10
Primary completion: 2027-01-09
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.